• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    7/17/24 1:28:51 PM ET
    $ADTX
    $ADVM
    $AEHR
    $ALLR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ADTX alert in real time by email

    Shares of ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) fell sharply during Wednesday's session after the company announced that its Singapore-incorporated, sole operating subsidiary has filed for voluntary liquidation.

    ASLAN Pharmaceuticals shares dipped 38.7% to $0.68 on Wednesday.

    Here are some other stocks moving in today’s mid-day session.

    Gainers

    • Aptevo Therapeutics Inc. (NASDAQ:APVO) shares climbed 84% to $0.6073 after surging around 10% on Tuesday. Aptevo Therapeutics recently announced closing of $2.75 million offering.
    • Shimmick Corporation (NASDAQ:SHIM) shares climbed 49% to $3.0173 after the company received a $27.6 million subcontract for the Sunol Valley Water Treatment Plant Ozonation Project.
    • Aditxt, Inc. (NASDAQ:ADTX) shares climbed 45.3% to $2.3107. Aditxt and Evofem amended merger agreement.
    • Locafy Limited (NASDAQ:LCFY) gained 31.2% to $7.15.
    • Autonomix Medical, Inc. (NASDAQ:AMIX) jumped 27.2% to $1.3505.
    • Alpha Teknova, Inc. (NASDAQ:TKNO) gained 18% to $1.60. Alpha Teknova 10% owner Telegraph Hill Partners Management Company, LLC bought a total of 12,096,773 shares at an average price of $1.24.
    • Asset Entities Inc. (NASDAQ:ASST) shares climbed 17% to $1.8350.
    • Meiwu Technology Company Limited (NASDAQ:WNW) gained 17% to $1.0650
    • Aehr Test Systems (NASDAQ:AEHR) gained 16.4% to $19.60 after the company reported better-than-expected Q4 financial results and issued FY25 revenue guidance above estimates. Also, the company announced it entered into a stock purchase agreement and made $12.7 million in orders for its FOX WaferPak full wafer Contractors.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) rose 14.5% to $0.2330. Allarity Therapeutics, last month, announced that it received notice from the NASDAQ Stock Market that it was granted a hearing.
    • ClearSign Technologies Corporation (NASDAQ:CLIR) gained 14.4% to $0.9499 as the company received initial order from Birwelco.
    • The Honest Company, Inc. (NASDAQ:HNST) gained 14% to $4.0350.
    • GLOBALFOUNDRIES Inc. (NASDAQ:GFS) climbed 12.7% to $61.36.
    • Bloom Energy Corporation (NYSE:BE) rose 9.4% to $16.50 after the company announced a strategic partnership with CoreWeave.
    • fuboTV Inc. (NYSE:FUBO) climbed 9.1% to $1.5610
    • GitLab Inc. (NASDAQ:GTLB) gained 8.4% to $54.92 following a report suggesting the company is exploring a sale.
    • Bloom Energy Corporation (NYSE:BE) rose 8% to $16.27 after the company announced a strategic partnership with CoreWeave.
    • V.F. Corporation (NYSE:VFC) gained 7.8% to $15.35 after the company announced it entered into a Stock and Asset Purchase Agreement to sell its Supreme brand to EssilorLuxottica for $1.5 billion in cash.

    Losers

    • Cassava Sciences, Inc. (NASDAQ:SAVA) fell 29.8% to $9.51 after announcing changes in executive leadership. The company named Rick Barry as Executive Chairman and Principal Executive Office and said Remi Barbier resigned as President, CEO, and Board Member.
    • 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) declined 20.9% to $21.16. 4DMT announced Phase 2 PRISM interim results for intravitreal 4D-150 in a broad wet AMD population affirming favorable safety profile and robust clinical activity.
    • Five Below, Inc. (NASDAQ:FIVE) shares dipped 19.7% to $81.93 after the company announced a CEO transition. Additionally, comparable sales decreased in the 10-week period ended July 13.
    • Sonim Technologies, Inc. (NASDAQ:SONM) fell 18.2% to $0.4138.
    • Adverum Biotechnologies, Inc. (NASDAQ:ADVM) dipped 16.3% to $7.46. Adverum Biotechnologies revealed 26-week interim analysis results of Ixo-vec from LUNA Phase 2 trial at 2024 ASRS Annual Meeting.
    • Structure Therapeutics Inc. (NASDAQ:GPCR) fell 16.2% to $37.44.
    • Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) fell 13.7% to $2.50.
    • Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) dipped 11.8% to $4.68.
    • Luminar Technologies, Inc. (NASDAQ:LAZR) fell 11.7% to $1.8974.
    • Viking Therapeutics, Inc. (NASDAQ:VKTX) dipped 10.8% to $50.89.
    • Onto Innovation Inc. (NYSE:ONTO) fell 10% to $214.17. Onto Innovation announced Dr. Stephen Schwartz has joined its board of directors.
    • ASML Holding N.V.  (NASDAQ:ASML) shares declined 9.8% to $963.01. ASML reported better-than-expected second-quarter earnings, driven by robust sales in China and a surge in new bookings.
    • Aurora Innovation, Inc. (NASDAQ:AUR) fell 9.5% to $4.46.
    • Nova Ltd. (NASDAQ:NVMI) declined 9.2% to $219.39.
    • Eightco Holdings Inc. (NASDAQ:OCTO) shares fell 9% to $0.48. Eightco Holdings recently said first-quarter revenue fell to $9.6 million from $15.9 million in the year-ago period.
    • Credo Technology Group Holding Ltd (NASDAQ:CRDO) dipped 8.8% to $30.87.
    • Siebert Financial Corp. (NASDAQ:SIEB) fell 8.5% to $1.7381 after gaining over 9% on Tuesday.
    • Spirit Airlines, Inc. (NYSE:SAVE) shares declined 8.4% to $2.8950 as the company issued soft second-quarter preliminary revenue estimates. The company estimated total revenue for the second quarter of 2024 to be approximately $1.28 billion, lower than previously expected primarily due to lower-than-expected non-ticket revenue.
    • Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) shares fell 8.1% to $1.3890 after jumping 41% on Tuesday.
    • Advanced Micro Devices, Inc. (NASDAQ:AMD) dipped 8% to $163.01.
    • Semtech Corporation (NASDAQ:SMTC) fell 7.4% to $33.66.
    • NaaS Technology Inc. (NASDAQ:NAAS) fell 7.3% to $4.32.
    • e.l.f. Beauty, Inc. (NYSE:ELF) declined 7.1% to $175.56.
    • Safe and Green Development Corporation (NASDAQ:SGD) shares dipped 7.1% to $0.38.
    • J.B. Hunt Transport Services, Inc. (NASDAQ:JBHT) fell 7% to $163.74 after the company reported worse-than-expected second-quarter financial results.
    • QUALCOMM Incorporated (NASDAQ:QCOM) fell 6.5% to $195.94 after HSBC downgraded the stock from Buy to Hold.
    • Snap Inc. (NYSE:SNAP) fell 6.3% to $15.11 after Donald Trump made comments in support of TikTok.
    • NVIDIA Corporation (NASDAQ:NVDA) fell 5.2% to $119.82. Shares of semiconductor stocks traded lower amid reports Biden is considering further China restrictions.

    Now Read This:

    • Alphabet, CrowdStrike And 2 Other Stocks Insiders Are Selling
    Get the next $ADTX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADTX
    $ADVM
    $AEHR
    $ALLR

    CompanyDatePrice TargetRatingAnalyst
    Nova Ltd.
    $NVMI
    3/11/2026$465.00Overweight
    Barclays
    Strive Inc.
    $ASST
    3/10/2026$12.00Buy
    B. Riley Securities
    QUALCOMM Incorporated
    $QCOM
    3/10/2026$145.00Underperform
    BofA Securities
    GitLab Inc.
    $GTLB
    3/4/2026$28.00Overweight → Neutral
    Piper Sandler
    GitLab Inc.
    $GTLB
    3/2/2026$29.00Buy → Hold
    TD Cowen
    Aehr Test Systems
    $AEHR
    3/2/2026Mkt Perform → Outperform
    William Blair
    Bloom Energy Corporation
    $BE
    2/24/2026$162.00Neutral
    Citigroup
    QUALCOMM Incorporated
    $QCOM
    2/24/2026$185.00Underweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $ADTX
    $ADVM
    $AEHR
    $ALLR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GlobalFoundries Announces Pricing of Public Secondary Offering and Concurrent Share Repurchase

    MALTA, N.Y., March 11, 2026 (GLOBE NEWSWIRE) -- GlobalFoundries (NASDAQ:GFS) (GF) today announced the pricing of a secondary public offering of 20,000,000 ordinary shares to the public at a price to the public of $42.00 per share and $300 million of ordinary shares to be repurchased by GF, as described below. All of the shares in the offering are being offered by Mubadala Technology Investment Company (the "Selling Shareholder"). The Selling Shareholder is a wholly owned subsidiary of Mubadala Investment Company PJSC (which, together with its affiliates, is GF's largest shareholder). The Selling Shareholder has also granted the underwriters a 30-day option to purchase up to an additional 3

    3/11/26 10:18:32 PM ET
    $GFS
    Semiconductors
    Technology

    GlobalFoundries Announces Launch of Public Secondary Offering and Concurrent Share Repurchase

    MALTA, N.Y., March 11, 2026 (GLOBE NEWSWIRE) -- GlobalFoundries (NASDAQ:GFS) (GF) today announced the launch of a secondary public offering of 20,000,000 ordinary shares to the public and approximately $300 million of ordinary shares to be repurchased by GF, as described below. All of the shares in the offering are being offered by Mubadala Technology Investment Company (the "Selling Shareholder"). The Selling Shareholder is a wholly owned subsidiary of Mubadala Investment Company PJSC (which, together with its affiliates, is GF's largest shareholder). The Selling Shareholder is expected to grant the underwriters a 30-day option to purchase up to an additional 3,000,000 of GF's ordinary sh

    3/11/26 5:16:55 PM ET
    $GFS
    Semiconductors
    Technology

    Strive Adds $50M of STRC to its Corporate Treasury

    Strategy Inc (NASDAQ:STRF, LuxSE: STRE)) ("Strategy") today announced that Strive, Inc. ("Strive") has allocated $50 million, representing over one-third of its corporate treasury, to STRC (Strategy's Variable Rate Series A Perpetual Stretch Preferred Stock). "We are encouraged to see innovative institutions continue integrating STRC into their treasury strategies," said Phong Le, Chief Executive Officer of Strategy. "Prevalon Energy, Anchorage Digital, and OranjeBTC have already added STRC to their corporate treasuries, and Strive is now the latest corporation to publicly announce doing so. Adoption continues to grow as more institutions recognize the role Digital Credit can play in mode

    3/11/26 9:00:00 AM ET
    $ASST
    $MSTR
    $STRC
    Computer Software: Prepackaged Software
    Technology
    Wholesale Distributors
    Industrials

    $ADTX
    $ADVM
    $AEHR
    $ALLR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on Nova Measuring with a new price target

    Barclays initiated coverage of Nova Measuring with a rating of Overweight and set a new price target of $465.00

    3/11/26 8:39:08 AM ET
    $NVMI
    Electronic Components
    Technology

    B. Riley Securities initiated coverage on Strive with a new price target

    B. Riley Securities initiated coverage of Strive with a rating of Buy and set a new price target of $12.00

    3/10/26 8:42:37 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    BofA Securities resumed coverage on Qualcomm with a new price target

    BofA Securities resumed coverage of Qualcomm with a rating of Underperform and set a new price target of $145.00

    3/10/26 8:41:55 AM ET
    $QCOM
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $ADTX
    $ADVM
    $AEHR
    $ALLR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    March 22, 2024 - FDA Roundup: March 22, 2024

    For Immediate Release: March 22, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]).  Pemgarda is

    3/22/24 5:02:42 PM ET
    $SNAP
    $SRAX
    Computer Software: Programming Data Processing
    Technology
    Advertising
    Consumer Discretionary

    November 9, 2023 - FDA Approves First Treatment for Patients with Rare Inherited Blood Clotting Disorder

    For Immediate Release: November 09, 2023 Today, the U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), a rare and life-threatening blood clotting disorder. “The FDA remains

    11/9/23 2:30:20 PM ET
    $SRAX
    $SNAP
    Advertising
    Consumer Discretionary
    Computer Software: Programming Data Processing
    Technology

    $ADTX
    $ADVM
    $AEHR
    $ALLR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Lowell Matthew bought $87,616 worth of shares (40,000 units at $2.19), increasing direct ownership by 31% to 168,376 units (SEC Form 4)

    4 - Alpha Teknova, Inc. (0001850902) (Issuer)

    3/9/26 4:30:28 PM ET
    $TKNO
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    President and CEO Gunstream Stephen bought $55,801 worth of shares (26,000 units at $2.15), increasing direct ownership by 11% to 269,497 units (SEC Form 4)

    4 - Alpha Teknova, Inc. (0001850902) (Issuer)

    3/9/26 4:24:28 PM ET
    $TKNO
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Director Farrell Matthew bought $464,814 worth of shares (5,000 units at $92.96), increasing direct ownership by 86% to 10,820 units (SEC Form 4)

    4 - e.l.f. Beauty, Inc. (0001600033) (Issuer)

    2/23/26 4:07:34 PM ET
    $ELF
    Package Goods/Cosmetics
    Consumer Discretionary

    $ADTX
    $ADVM
    $AEHR
    $ALLR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, General Counsel and Sec Teter Timothy S. was granted 47,048 shares, increasing direct ownership by 10% to 524,795 units (SEC Form 4)

    4 - NVIDIA CORP (0001045810) (Issuer)

    3/11/26 6:15:53 PM ET
    $NVDA
    Semiconductors
    Technology

    EVP & Chief Financial Officer Kress Colette was granted 47,048 units of Common, increasing direct ownership by 5% to 1,000,572 units (SEC Form 4)

    4 - NVIDIA CORP (0001045810) (Issuer)

    3/11/26 6:12:42 PM ET
    $NVDA
    Semiconductors
    Technology

    EVP, Operations Shoquist Debora was granted 47,048 shares, increasing direct ownership by 8% to 621,907 units (SEC Form 4)

    4 - NVIDIA CORP (0001045810) (Issuer)

    3/11/26 6:14:29 PM ET
    $NVDA
    Semiconductors
    Technology

    $ADTX
    $ADVM
    $AEHR
    $ALLR
    Leadership Updates

    Live Leadership Updates

    View All

    ASML publishes agenda Annual General Meeting 2026

    ASML publishes agenda Annual General Meeting 2026Appointment and reappointment of Board of Management members and changes in Supervisory Board announced VELDHOVEN, the Netherlands, March 9, 2026 – Today, ASML Holding NV (ASML) has published the agenda for the 2025 Annual General Meeting (AGM) which will be held in ASML's TWINSCAN Auditorium in Veldhoven on Wednesday, April 22, 2026, starting at 10:00 CET. The agenda with the explanatory notes and other meeting documents are available at www.asml.com/agm2026. Appointment and reappointment of Board of Management membersAs announced on October 9, 2025, subject to the notification of the General Meeting on April 22, 2026, the ASML Supervisory

    3/9/26 3:00:00 AM ET
    $ASML
    Industrial Machinery/Components
    Technology

    Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board

    –Received Positive Pre-Investigational New Drug ("IND") Written Feedback from the U.S. Food and Drug Administration ("FDA")– –Clinical Advisory Board ("CAB") Includes Key Leaders across Neuropsychiatry, Anesthesiology, and Clinical Development– –Remain On Track to Initiate CYC-126's Phase 2 Proof-of-Concept ("POC") Study in Treatment Resistant Depression ("TRD") in the Second Half of 2026– CAMBRIDGE, Mass., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) ("Cyclerion" or "Company"), a biopharmaceutical company pioneering neuropsychiatric therapies, today announced it has received positive written regulatory feedback and responses from the FDA on CYC-126

    2/17/26 7:00:00 AM ET
    $CYCN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    $ADTX
    $ADVM
    $AEHR
    $ALLR
    SEC Filings

    View All

    SEC Form 6-K filed by GlobalFoundries Inc.

    6-K - GLOBALFOUNDRIES Inc. (0001709048) (Filer)

    3/11/26 5:20:41 PM ET
    $GFS
    Semiconductors
    Technology

    SEC Form FWP filed by Strive Inc.

    FWP - Strive, Inc. (0001920406) (Subject)

    3/11/26 5:12:48 PM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    SEC Form 424B7 filed by GlobalFoundries Inc.

    424B7 - GLOBALFOUNDRIES Inc. (0001709048) (Filer)

    3/11/26 5:02:51 PM ET
    $GFS
    Semiconductors
    Technology

    $ADTX
    $ADVM
    $AEHR
    $ALLR
    Financials

    Live finance-specific insights

    View All

    Strive Adds $50M of STRC to its Corporate Treasury

    Strategy Inc (NASDAQ:STRF, LuxSE: STRE)) ("Strategy") today announced that Strive, Inc. ("Strive") has allocated $50 million, representing over one-third of its corporate treasury, to STRC (Strategy's Variable Rate Series A Perpetual Stretch Preferred Stock). "We are encouraged to see innovative institutions continue integrating STRC into their treasury strategies," said Phong Le, Chief Executive Officer of Strategy. "Prevalon Energy, Anchorage Digital, and OranjeBTC have already added STRC to their corporate treasuries, and Strive is now the latest corporation to publicly announce doing so. Adoption continues to grow as more institutions recognize the role Digital Credit can play in mode

    3/11/26 9:00:00 AM ET
    $ASST
    $MSTR
    $STRC
    Computer Software: Prepackaged Software
    Technology
    Wholesale Distributors
    Industrials

    Strive Announces SATA Enhancements and Purchase of Bitcoin & STRC

    DALLAS, March 11, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. (NASDAQ:ASST, SATA)) ("Strive" or the "Company") today announced the following updates: SATA dividend rate increased by 25 bps to 12.75%. Dividend declared of $1.0625 per share of SATA Stock to stockholders of record the close of business on April 1, 2026, payable on April 15, 2026Targeted SATA price range narrowed to $99-$101 from $95-$105Updated guidance to not issue SATA via ATM or follow-on offerings below $100.00Purchased 179 additional Bitcoin since last filing and now holds approximately 13,311 BTCPurchased $50 million (500,000 shares) of Strategy Variable Rate Series A Perpetual Stretch Preferred Stock (NASDAQ:STRC)SATA divid

    3/11/26 8:00:00 AM ET
    $ASST
    $STRC
    Computer Software: Prepackaged Software
    Technology
    Wholesale Distributors
    Industrials

    Five Below, Inc. Announces Fourth Quarter and Full Year Fiscal 2025 Earnings Release and Conference Call Date

    PHILADELPHIA, PA, March 04, 2026 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ:FIVE) today announced that its financial results for the fourth quarter and full year of fiscal 2025 will be released after market close on Wednesday, March 18, 2026. The company will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results. A live audio webcast of the conference call will be available online at investor.fivebelow.com, where a replay will be available shortly after conclusion of the call. Investors and analysts interested in participating in the call are invited to dial 412-902-6753 approximately 10 minutes prior to the start of the call. Forward-Looking Statements:This

    3/4/26 4:01:00 PM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    $ADTX
    $ADVM
    $AEHR
    $ALLR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Spirit Airlines Inc.

    SC 13G - Spirit Airlines, Inc. (0001498710) (Subject)

    12/6/24 9:37:58 AM ET
    $SAVE
    Air Freight/Delivery Services
    Consumer Discretionary

    SEC Form SC 13G filed by Autonomix Medical Inc.

    SC 13G - Autonomix Medical, Inc. (0001617867) (Subject)

    12/3/24 6:17:58 PM ET
    $AMIX
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Autonomix Medical Inc.

    SC 13G - Autonomix Medical, Inc. (0001617867) (Subject)

    11/27/24 10:15:18 AM ET
    $AMIX
    Medical/Dental Instruments
    Health Care